A study conducted by physician-scientists from Assam Medical College Hospital revealed that 55% of Covishield vaccine recipients experienced only minor side effects like fever and headache, with no long-term adverse effects observed after a year. Led by Gayatri Gogoi, the study followed participants from July 2021 to June 2022, analyzing the vaccine’s effectiveness and adverse events. Younger individuals showed more minor adverse events, while those with comorbidities had fewer. The study, published in the Journal of Family Medicine and Primary Care, noted that natural virus infections resulted in stronger immune responses compared to the vaccine alone. The research highlights the real-time data from Dibrugarh district, offering valuable insights into Covishield’s safety and effectiveness in the region.
Covishield Study Reveals Minor Side Effects and Strong Antibody Response
![](https://affairsace-media.s3.ap-south-1.amazonaws.com/2024/05/05130026/ezgif.com-webp-to-jpg-converter-2-1.jpg)